Ágota Kovács

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

Mária Papp, I Altorjay, Nir Dotan et al. · The American Journal of Gastroenterology · 2008 · 147 citations

Medicine, Immunology, Pathobiology +17

IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease

A. Nemetz, M. P. Nosti-Escanilla, Tamás Molnár et al. · Immunogenetics · 1999 · 144 citations

Life Sciences, Genetics, Immunology +14

The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine

Wolfgang Kruis, Simon Bar–Meir, János Fehér et al. · Clinical Gastroenterology and Hepatology · 2003 · 114 citations

Medicine, Pharmacology, Pharmacotherapy +13

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis

Simon Bar–Meir, Alexandra Lavy, O Mickisch et al. · Alimentary Pharmacology & Therapeutics · 2005 · 95 citations · Full text

Nursing, Internal Medicine, Pharmacotherapy +17

Antioxidant Defense in Erythrocytes and Plasma of Patients with Active and Quiescent Crohn Disease and Ulcerative Colitis: A Chemiluminescent Study

Anna Blázovics, Ágota Kovács, Andrea Lugasi et al. · Clinical Chemistry · 1999 · 81 citations · Full text

Life Sciences, Biochemistry, Immunology +16